scholarly article | Q13442814 |
P356 | DOI | 10.1089/GTMB.2013.0424 |
P698 | PubMed publication ID | 24512523 |
P50 | author | Maher Albitar | Q66429840 |
P2093 | author name string | Herbert A Fritsche | |
Neal Shore | |||
Wanlong Ma | |||
Kevin Diep | |||
P433 | issue | 3 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 156-163 | |
P577 | publication date | 2014-02-10 | |
P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
P1476 | title | Diagnostic and prognostic scoring system for prostate cancer using urine and plasma biomarkers | |
P478 | volume | 18 |
Q41242753 | A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy. |
Q97569956 | Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review |
Q35014849 | Computational gene expression modeling identifies salivary biomarker analysis that predict oral feeding readiness in the newborn |
Q38916152 | Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies |
Q86166046 | Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer |
Q64076235 | Glycans as Biomarkers in Prostate Cancer |
Q47097189 | High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer |
Q42462891 | Immunohistochemical expression of heat shock proteins, p63 and androgen receptor in benign prostatic hyperplasia and prostatic carcinoma in the dog. |
Q28085759 | Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes |
Q38325768 | Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System |
Q48282722 | Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer |
Q38259961 | The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer. |
Q39214638 | miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men. |
Search more.